Stay updated on Dolutegravir Plus NRTIs in HIV-2 Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The 403 Forbidden page’s footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:14:44.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now displayed, replacing the study details with a simple error message and a Home link.
    Difference
    17%
    Check dated 2026-09-22T22:20:34.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.6 to v3.7.0, representing a version update of the page. This change does not alter the study details or content presented on the page.
    Difference
    0.1%
    Check dated 2026-09-15T20:52:51.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The Revision label in the page footer was updated from v3.6.5 to v3.6.6, indicating a new version of the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-09-01T18:03:39.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page's revision label has been updated from v3.6.4 to v3.6.5, signaling a minor update to the page template or content without changing the study data.
    Difference
    0.1%
    Check dated 2026-08-11T19:28:11.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.6.4 was added and Revision: v3.6.3 removed, updating the page’s revision label to reflect a new version. This change is a metadata update rather than a modification to the study content or data.
    Difference
    0.1%
    Check dated 2026-07-28T15:11:38.000Z thumbnail image

Stay in the know with updates to Dolutegravir Plus NRTIs in HIV-2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.